Tate & Lyle PLC

Tate & Lyle and its subsidiaries are engaged in providing ingredients and solutions to the food, beverage and other industries. Co. has two segments: Specialty Food Ingredients (SFI) and Bulk Ingredients (BI). The SFI segment develops ingredients and solutions for customers globally for food and drink. Co. focuses on three areas of this market: texturants, sweeteners, and health and wellness. The BI segment provides food ingredients and industrial products primarily for customers in the North American market. The main product lines include: bulk sweeteners, industrial starches, acidulants, and commodities.
  • TickerTATE
  • ISINGB0008754136
  • ExchangeLondon Stock Exchange
  • SectorFood Producers
  • CountryUnited Kingdom

Analysts

Tate & Lyle plc - March 2017 (LTM): Peer Snapshot

Peer Snapshot:  Tate & Lyle plc - March 2017 (LTM) 11 July 2017 (in US millions) FYE Mar-15 FYE Mar-16 LTM Mar-17 FYE Dec-15 FYE Dec-16 LTM Mar-17 FYE Feb-15 FYE Feb-16 LTM Feb-17

Adam Kindreich, CFA

Dropping Coverage of Tate & Lyle

We are no longer providing equity research on the following companies: Chr. Hansen, Tate & Lyle, Kerry Group, Glanbia, Chocoladefabriken Lindt & Spruengli, and Geox. We provide broad coverage of more than 1,400 companies across more than 140 industries and adjust our coverage as necessary based on client demand....

Adam Kindreich, CFA

Tate & Lyle: Upbeat Tone to Third-Quarter Trading Statement

Tate & Lyle, the starch and sweetener ingredients manufacturer, reported an upbeat trading performance in the third quarter ended December 2016. Trends were little changed from the first half, with bulk ingredients doing well, offset by a more challenged speciality business. We maintain our no-moat rating and our GBX 680 fair value estimate, with the shares offering poor value at current levels. Not only has North American bulk sweetener volume remained robust, but the sweetener pricing roun...

Adam Kindreich, CFA

Upgrading Tate & Lyle Estimates and Valuation on Continuing Sterling Weakness

Given the continuing weakness of the British pound sterling against major currencies such as the euro and the U.S. dollar since the U.K.'s EU referendum in June 2016, we are upgrading our earnings forecasts and fair value estimate for Tate & Lyle. Our new fair value estimate is GPX 590 per share, up 7%, but shares remain overvalued at current levels. Our no-moat and stable moat trend ratings are unchanged. While Tate & Lyle is domiciled in the United Kingdom, the company generates only 1...

Tate & Lyle plc - March 2017 (LTM): Peer Snapshot

Peer Snapshot:  Tate & Lyle plc - March 2017 (LTM) 11 July 2017 (in US millions) FYE Mar-15 FYE Mar-16 LTM Mar-17 FYE Dec-15 FYE Dec-16 LTM Mar-17 FYE Feb-15 FYE Feb-16 LTM Feb-17

Adam Kindreich, CFA

Dropping Coverage of Tate & Lyle

We are no longer providing equity research on the following companies: Chr. Hansen, Tate & Lyle, Kerry Group, Glanbia, Chocoladefabriken Lindt & Spruengli, and Geox. We provide broad coverage of more than 1,400 companies across more than 140 industries and adjust our coverage as necessary based on client demand....

Adam Kindreich, CFA

Tate & Lyle: Upbeat Tone to Third-Quarter Trading Statement

Tate & Lyle, the starch and sweetener ingredients manufacturer, reported an upbeat trading performance in the third quarter ended December 2016. Trends were little changed from the first half, with bulk ingredients doing well, offset by a more challenged speciality business. We maintain our no-moat rating and our GBX 680 fair value estimate, with the shares offering poor value at current levels. Not only has North American bulk sweetener volume remained robust, but the sweetener pricing roun...

Adam Kindreich, CFA

Upgrading Tate & Lyle Estimates and Valuation on Continuing Sterling Weakness

Given the continuing weakness of the British pound sterling against major currencies such as the euro and the U.S. dollar since the U.K.'s EU referendum in June 2016, we are upgrading our earnings forecasts and fair value estimate for Tate & Lyle. Our new fair value estimate is GPX 590 per share, up 7%, but shares remain overvalued at current levels. Our no-moat and stable moat trend ratings are unchanged. While Tate & Lyle is domiciled in the United Kingdom, the company generates only 1...

Adam Kindreich, CFA

Tate & Lyle is moving up the value chain in sweetener ingredients.

Tate & Lyle, or T&L, had a mixed start to the year, during the first three months to end June. The company didn't divulge precise figures, but bulk ingredients' profitability is up strongly, while speciality ingredients' profitability, typically a far higher margin than bulk, is up, but not strongly. This is a reversal of the long-term trends we would expect to see, but are mostly the result of one-off factors. We maintain our no-moat and stable moat trend ratings and our fair value esti...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch